Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03233867 · ClinicalTrials.gov registry record
A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations
A clinical trial, sponsored by Aevi Genomic Medicine, LLC, a Cerecor company.
- Completed
- Registry status
- 2,503
- Enrollment target
NCT03233867 is a clinical trial that has completed, run by Aevi Genomic Medicine, LLC, a Cerecor company. The registered enrollment target is 2,503 participants.
The verdict
NCT03233867 has completed, sponsored by Aevi Genomic Medicine, LLC, a Cerecor company.
- COMPLETED
- Registry status
- 2,503 participants
- Enrollment target
Study Summary
This is a non-interventional study in children and adolescents (ages 6-17 years) with attention deficit hyperactivity disorder (ADHD) to assess CNVs in specific genes involved in glutamatergic signaling and neuronal connectivity. The screening in this study will be conducted through a combination of online and site performed activities.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,503 participants |
| Start Date | 2017-08-14 |
| Est. Completion | 2018-08-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03233867
The ClinicalTrials.gov registry entry for NCT03233867 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,503 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aevi Genomic Medicine, LLC, a Cerecor company, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03233867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03233867 about?
NCT03233867 is a clinical study titled "A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations". This is a non-interventional study in children and adolescents (ages 6-17 years) with attention deficit hyperactivity disorder (ADHD) to assess CNVs in specific genes involved in glutamatergic signaling and neuronal connectivity. The screening in this study will be conducted through a combination of...
What is the current status of trial NCT03233867?
This trial is currently completed. The enrollment target is 2,503 participants. The study started on 2017-08-14. Estimated completion is 2018-08-03.
Who is sponsoring clinical trial NCT03233867?
This trial is sponsored by Aevi Genomic Medicine, LLC, a Cerecor company, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.